24

nanotimes

Companies Facts

I

n an interview with Capital Situation, Michael Siegel, CEO of EcoloCap Solutions of Chicago,

USA, stated that numerous independent tests have proven the company’s M-Fuel technology to reduce consumption of diesel fuel up to 30% while redu- cing emissions by over 70%, without any modifica- tions to diesel engines of buses and trucks. Invented using nanotechnology, M-Fuel is an emul- sion of diesel fuel, water and a proprietary additive, developed by EcoloCap’s Korean team over the last few years. The Company is presently marketing the technology worldwide, having orders and memoran- dum of understanding with, governments, transporta- tion and utility companies in over ten countries.

Siegel stated: “Taking an example in our own back- yard, the skyrocketing price of diesel fuel will cost Chicago and Chicago‘s transit agencies tens of millions of dollars more than anticipated this year, jeopardizing some proposed new services. With fuel costs rising and state funds scarce, the region‘s mass transit agencies face a budget season full of tough de- cisions that could create a bumpy ride for passengers. The City of Chicago, along with Pace, the CTA, and Metra spend an estimated $200M in diesel fuel each year. The use of EcoloCap’s M-Fuel would save a minimum of 20% or some $40M annually, and that’s using the most conservative of our projections.”

Siegel added: “Another factor is that under the 2003 Clean Air Act [U.S.], emulsified diesel fuels with a minimum 12.5% water make users eligible for an ad- ditional $0.197 IRS Tax Credit. As a result, end users could save up to $1.00 a gallon on the cost of diesel fuel at today’s prices.” http://www.ecolocap.com

E E

lionix Inc. announced a second order placed by Harvard‘s Center for Nanoscale Systems for the

Elionix ELS-F125 electron beam lithography system. http://www.sts-elionix.com

NVISION ALR is commercialising a new form of nanotechnology based infectious disease detec-

tion system with the capability to distinguish between different flu strains within seconds. The technology has already been shown to be effective in lab tests and the company is accelerating the commerciali- sation program. The technology is based on printed electronics, making use of the unique properties of a number of nanoparticle based inks and is rapid, accurate, and the hand held device is easily portable for use in doctors surgeries, hospitals or airports. The system works for both bacterial and viral pathogens, and tests performed by the Naval Research Lab in Washington DC using Staphylococcus Enterotoxin B showed a two order of magnitude improvement over the current ‚Lab Golden Standard‘ test. http://envisionalr.co.uk

F

luidigm Corporation (NASDAQ:FLDM) has intro- duced its 192.24 Dynamic Array™ IFC, designed

to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnolo- gy and genome wide association studies. Fluidigm‘s latest integrated fluidic circuit features an innovative design that greatly increases sample throughput for common SNP genotyping applications. Moreover, Fluidigm has announced that the Broad Institute of MIT and Harvard has purchased an

11-05 :: May/June 2011